Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses

Redcliffe Labs has posted ₹419 crore revenue in FY25 and narrowed EBITDA losses. These financial results indicate significant growth in the diagnostics and healthcare sector for Redcliffe Labs. While achieving substantial revenue, the narrowing of EBITDA losses suggests improved operational efficiency and a positive trajectory towards profitability. These figures are crucial for assessing the company's financial health and its ability to scale sustainably in the competitive healthcare industry, demonstrating a path towards better financial performance.